TAT and cancer: Supporting a role for PF1 in cancer stem cell maintenance and in agreement with Tat-SID data, PF1 knockdown resulted in a 2.5-fold decrease in ALDH1 positive cells (6.55% in Scr-shRNA versus 2.59% in PF1-shRNA; Figure 8A).